Preventing severe infection after splenectomy

Preventing severe infection after splenectomy - PRESIS

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON29806

Enrollment

Registered

2006-09-05

Start date

2006-09-29

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

loss of function of the spleen splenectomy

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: patients who underwent a splenectomy in the period 1995-2005 in the area of Utrecht and are older than 18 years Patient who are (functional) asplenic because of sickle cell anemia, sferocytosis, ITP or a Hodgkin lymphoma and are older than 18 years

Exclusion criteria

Exclusion criteria: -Patients who underwent a splenectomy in the period 1995-2005 in the area of Utrecht and are younger than 18 years. -Patient who are (functional) asplenic because of sickle cell anemia, ITP, sferocytosis or a Hodgkin lymphoma who are younger than 18 years -Patients who are unable to give informed consent

Design outcomes

Primary

Measure	Time frame
IgG-antibody titer (U/L) against Streptococcus Pneumoniae, Haemophilus influenzae en Neisseria Meningitidis	—

Secondary

Measure	Time frame
-Percentage of patiënts that is vaccinated against Streptococcus Pneumoniae, Haemophilus influenzae en Neisseria Meningitidis -Percentage of patiënts that is revaccinated against Streptococcus Pneumoniae, Haemophilus influenzae en Neisseria Meningitidis -Percentage of patiënts that is informed about the infectious risks of a (functional) asplenia.	—

Countries

Netherlands

Outcome results